| |
著者: Deting Xue, Fangcai Li, Gang Chen, Shigui Yan, Zhijun Pan
雑誌名: J Orthop Surg Res. 2014 Jun 5;9:45. doi: 10.1186/1749-799X-9-45. Epub 2014 Jun 5.
Abstract/Text
BACKGROUND: Whether bisphosphonates affect indirect bone healing is still unclear.
METHOD: We carried out a comprehensive search strategy. Only randomized controlled trials were included. Two reviewers independently assessed methodological qualities and extracted outcome data. Analysis was performed with RevMan 5.2.
RESULTS: Eight eligible randomized controlled trials with 2,508 patients were included. Meta-analysis results showed that no statistically significant differences were founded in indirect bone healing in short time (within 3 months) (relative risk (RR) 1.40, relative the control group; 95% CI 0.36 to 5.49) and in long-term (more than 12 months) postoperation (RR 1.0; 95% CI 0.98 to 1.02) between bisphosphonates infusion groups and control groups. There were no statistically significant differences of indirect bone healing between early and delay bisphosphonates administration groups. Bisphosphonates infusion after lumbar infusion surgery could promote bone healing and shorten fusion time in 6 months postoperation (RR 1.35; 95% CI 1.11 to 1.66).
CONCLUSION: There was no clinically detectable delay to fracture healing via external callus formation following bisphosphonates treatment. Considering the benefit aspects of bisphosphonates for osteoporosis treatment, we recommend bisphosphonates infusion after fracture fixation surgery and lumbar fusion surgery.
PMID 24902588 J Orthop Surg Res. 2014 Jun 5;9:45. doi: 10.1186/1749-799X-9-45. Epub 2014 Jun 5.
|
